Comprehensive Urology Care for Advanced Practice Providers:
Mastering Inpatient and Outpatient Management

Advanced Practice Providers (APP) and nurses are essential to delivering high-quality urologic care, and this CME/NCPD program—presented by the Fox Chase – Temple Urologic Institute—offers a focused, hands-on opportunity to deepen that expertise. Participants will gain targeted updates in general urology and urologic oncology, explore evolving diagnostic and management strategies, and strengthen procedural skills through interactive workshops and simulation-based training. Led by experienced clinicians, the program equips attendees with practical knowledge, clinical confidence, and evidence-based approaches to elevate patient care across all urologic settings. NCPD and AMA PRA Category 1 credits will be provided for this program.
DATES & TIMES:
Thursday, June 11, 2026 I 7:30am – 4:00pm
Friday, June 12, 2026 I 7:30am – 5:00pm
LOCATION:
Philadelphia (venue to be announced)
PROGRAM DIRECTOR

Andres F. Correa, MD
Director of Research & Associate Professor,
Department of Urology, Fox Chase Cancer Center
Alexander Kutikov, MD, FACS
Chair and Professor, Department of Urology;
Roberta R. Scheller Chair in Urologic Oncology,
Fox Chase Cancer Center

Sarah Leach, PA-C
Advanced Practice Provider, Department of Urology,
Fox Chase Cancer Center

Elena Dreyzin, PA-C
Advanced Practice Provider, Department of Urology,
Fox Chase Cancer Center
AGENDA:
DAY 1 — Thursday, June 11, 2026
|
7:30 – 8:00 AM |
Welcome, Breakfast & Exhibit Hall |
|
8:00 – 10:00 AM |
General Urology – Part One 8:00 – 8:30 AM — Anatomy & Physiology of the Genitourinary System Overview of the genitourinary system with emphasis on structures relevant to urology. 8:30 – 9:00 AM — Diagnostic Imaging in Urology Techniques and modalities: ultrasound, CT, MRI, and PET imaging. 9:00 – 9:30 AM — Benign Urological Conditions BPH diagnosis and management of male and female lower urinary tract symptoms (LUTS). 9:30 – 10:00 AM — Urolithiasis & Urinary Tract Infections Dietary and medical management, surgical interventions, and special considerations in stone disease.
|
|
10:00 – 10:30 AM |
Exhibitor Break & Refreshments |
|
10:30 AM – 12:30 PM |
General Urology – Part Two 10:30 – 11:00 AM — Pelvic Floor Dysfunction: Diagnosis & Management Focus on male and female pelvic floor disorders, including diagnosis and therapeutic approaches. 11:00 – 11:30 AM — Indication and Management of Stents, PCNs, and Role of IR in Tube Management Management of post-op retention, post-op complications, gross hematuria, the indications and management of ureteral stents, percutaneous nephrostomy tubes (PCNs), and the role of interventional radiology (IR) in tube management. 11:30 AM – 12:00 PM — Urologic Emergencies Diagnosis and management of torsion, priapism, Fournier’s gangrene, penile fracture, urosepsis, trauma, and paraphimosis. 12:00 – 12:30 PM — Reconstructive Urology, Urologic Trauma & Prosthetics Techniques of urethral stricture disease, bladder reconstruction, managing genitourinary trauma and urologic prosthetic devices including artificial urinary sphincters (AUS) and inflatable penile prostheses (IPP). |
|
12:30 – 1:30 PM |
Lunch & Exhibitor Break |
|
1:30 – 4:00 PM |
Hands-On Activities (Rotating Stations) and Exhibit Hall • Use of Ultrasound in the Office • BPH Management (small group case discussion) • Kidney Stone Management — Diet, Supplements, and Medications (small group case discussion) • Management of Foleys, Stents, Drains, & Nephrostomy Tubes • IPP & AUS Hands-on Simulation • Management of Complex LUTS (small group case discussion) |
|
4:00 PM |
Day 1 Concludes |
DAY 2 — Friday, June 12, 2026
|
7:30 – 8:00 AM |
Welcome, Breakfast & Exhibit Hall |
|
8:00 – 10:00 AM |
Urologic Oncology – Part One 8:00 – 8:30 AM — PSA Screening & Monitoring Overview of PSA screening, monitoring strategies, and available risk-stratifying tests. 8:30 – 9:00 AM — Prostate Cancer Imaging & Biopsy Techniques Review of prostate imaging (MRI and ultrasound), biopsy methods (TRUS, MRI-guided biopsy, etc.) and decision-making in management. 9:00 – 9:30 AM — Prostate Cancer Management: Localized Localized prostate cancer, risk stratification, treatment and follow-up. 9:30 – 10:00 AM — Prostate Cancer Management: Metastatic Management of metastatic prostate cancer and review of important tests that should be checked. |
|
10:00 – 10:30 AM |
Exhibit Hall Break & Refreshments |
|
10:30 AM – 12:30 PM |
Urologic Oncology – Part Two 10:30 – 11:00 AM — Urothelial Carcinoma: Localized Management of bladder cancer (NMIBC and MIBC) and upper tract urothelial carcinoma (UTUC). 11:00 – 11:30 AM — Kidney Cancer: Localized Diagnosis, staging, treatment options and follow-up. 11:30 AM – 12:00 PM — Testicular & Penile Cancers Diagnosis, staging, treatment options, and survivorship strategies. 12:00 – 12:30 PM — Systemic Therapy: What to Know from a Urology Perspective Overview of common GU cancer medications, side effects, and identification of emergent presentation (immunotherapy). |
|
12:30 – 1:30 PM |
Lunch & Exhibit Hall Break |
|
1:30 – 4:00 PM |
Hands-On Activities (Rotating Stations) and Exhibit Hall • Wound/Ostomy Nurse Demonstrations • Cystoscopy • Management of NMIBC (small group discussion) • Imaging in Uro-Oncology (small group discussion) • Management of Elevated PSA (small group discussion) • Managment of Uro-Oncology Medication Side Effects (small group discussion) • Gross Hematuria Management — Foley Selection and Bladder Irrigation. |
|
4:30 – 5:00 PM |
Closing Remarks & Program Conclusion |
INTENDED AUDIENCE:
The program is designed for physicians, advanced practice providers; nurses; and healthcare professionals involved in the treatment of patients with genitourinary cancers.
ACCREDITATION STATEMENT:
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
DESIGNATION STATEMENT:
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 13.5 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.
INQUIRIES:
Lucía Tono, PhD, MEd


